ROCHE HOLDING LTD. : Roche reports positive studies of MabThera given by …4-tradersRoche (SIX: RO, ROG; OTCQX: RHHBY) today announced results from two studies which showed that a fixed dose of MabThera (rituximab) can be administered subcutaneously (…
AbbVie's Life After AbbottMotley FoolOne of the drugs the company pins future hopes on is daclizumab, which is used to treat relapsing multiple sclerosis. A phase 3 clinical trial is currently under way for the drug in collaboration with Biogen (NA…
Data Presented at American Society of Hematology from Ibrutinib Phase 1b/2 …The Herald | HeraldOnline.comA second study in 40 patients with HR CLL treated with the combination of ibrutinib and rituximab therapy reported an ORR of 83 percent, with 38 …
Clinical Oncology NewsHematology & Stem Cell Transplantation ProgramClinical Oncology NewsThe majority of clinical responses with SAR3419 were seen in patients with follicular lymphoma, including those who were rituximab refractory. SAR3419 (huB4-D…
B-cell alterations in ME/CFS 'may suggest subtle tendency to autoimmunity'ProHealthHowever, treatment with anti-B-cell therapy using Rituximab has recently shown benefit to CFS patients. We therefore postulated that patients with CFS had a subt…
Rethinking therapy decisions in autoimmune encephalopathyNews-Medical.netFirst-line immunotherapies (corticosteroids, intravenous immunoglobulins, and plasma exchange) were given to 29 patients, while five required regular immunosuppressive treatment w…
Mundipharma to present bendamustine data at ASH meetingPharmaceutical Business ReviewTwo oral and three poster presentations will present summary on indolent NHL (iNHL) and MCL, comparing treatment with bendamustine-rituximab (B-R) to the standard firs…
MedscapeWhat's Hot at ASH This Year?MedscapeToxicity is a problem in the treatment of CLL, where the standard therapy is a combination of fludarabine, cyclophosphamide, and rituximab. This improves outcomes, but is reasonably toxic for older patien…
Kirkman appreciates MLB's Stand Up To CancerTexasRangers.comKirkman, while playing for Round Rock, began a series of treatments with a chimeric monoclonal antibody called Rituximab, which destroys the b cells that cause the cancer. He was scheduled…
Record Number of Bendamustine Abstracts Accepted for Presentation at the …SYS-CON Media (press release)Two oral and three poster presentations focus on indolent NHL (iNHL) and MCL, comparing treatment with bendamustine-rituximab (B-R) to the standard…